Back to search results

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia

Abroad (travel likely)RecruitingPHASE2

Conditions

Achondroplasia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ascendis Investigational Site, Saint Paul, Minnesota, United States

  • Ascendis Investigational Site, Houston, Texas, United States

  • Ascendis Investigational Site, Madison, Wisconsin, United States

  • Ascendis Investigational Site, Parkville, Australia

  • Ascendis Investigational Site, Linz, Austria

  • Ascendis Investigational Site, Montreal, Canada

  • Ascendis Investigational Site, Copenhagen, Denmark

  • Ascendis Investigational Site, Helsinki, Finland

  • Ascendis Investigational Site, Paris, France

  • Ascendis Investigational Site, Berlin, Germany

  • Ascendis Investigational Site, Cologne, Germany

  • Ascendis Investigational Site, Dublin, Ireland

  • Ascendis Investigational Site, Milan, Italy

  • Ascendis Investigational Site, Auckland, New Zealand

  • Ascendis Investigational Site, Oslo, Norway

  • Ascendis Investigational Site, Coimbra, Portugal

  • Ascendis Investigational Site, Stockholm, Sweden

  • Ascendis Investigational Site, London, United Kingdom

Study leads

  • Medical Director, MD

    Study Director

    Ascendis Pharma A/S

View source on ClinicalTrials.gov(opens in a new tab)